Paraproteinemias
Clinical trials for Paraproteinemias explained in plain language.
Never miss a new study
Get alerted when new Paraproteinemias trials appear
Sign up with your email to follow new studies for Paraproteinemias, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a cancer drug rescue kidneys harmed by rogue antibodies?
Disease control Recruiting nowResearchers are testing whether the drug daratumumab can treat kidney diseases caused by monoclonal gammopathy of renal significance (MGRS), a group of conditions where abnormal antibody proteins damage the kidneys. The trial enrolls 30 adults with biopsy-confirmed MGRS. Particip…
Matched conditions: PARAPROTEINEMIAS
Phase 2 • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Gene therapy builds Cancer-Killing cells inside you – no lab needed
Disease control Recruiting nowThis early-stage trial tests a new gene therapy called KLN-1010 for people with multiple myeloma that has come back or stopped responding to treatment. Instead of removing cells and engineering them in a lab, this therapy works inside the body to create special immune cells that …
Matched conditions: PARAPROTEINEMIAS
Phase 1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC